Funding for this training was made possible, in part, by the Pacific Southwest Addiction Technology Transfer Center, HHS Region 9, cooperative agreement 1H79TI087732 from the Substance Abuse and Mental Health Services Administration. To learn more about the Pacific Southwest ATTC visit their website at http://www.psattc.org.
Description
The purpose of this training is to provide participants with a detailed overview ofmedications that have been shown to be effective as a component of the treatment ofalcohol use disorder. Topics will include: the context for medications for addictiontreatment (positive and negative perceptions); the epidemiology of alcohol use andalcohol use disorder; a review of each FDA-approved medication, its indication, towhom it is administered, and how it works; and treatment settings for medication foralcohol use disorder treatment. Medications will include: acamprosate, disulfiram, andnaltrexone. The training will conclude with a session on talking with clients who areambivalent about medications, and strategies to increase access and engage patientsin care. Time will be provided throughout the training for discussion and questions.
Learning Objectives
By the end of this presentation, participants will:
-
Name at least three (3) acute and chronic effects of alcohol.
-
Identify the prevalence of and list three (3) key populations impacted by alcohol use disorder.
-
Specify three (3) medications that are available to treat alcohol use disorder.
-
Apply at least two (2) strategies that can be used to increase patient engagement and access to medications for alcohol use disorder.
Presented by:
Thomas E. Freese, PhD. and Beth A. Rutkowski, MPH
Thomas E. Freese, PhD., is the Director of the UCLA Integrated Substance Use andAddiction Programs (ISAP) and Adjunct Professor in the Department of Psychiatry.Additionally, he serves as Director of Training and Dissemination for the Division ofAddiction Psychiatry in the David Geffen School of Medicine at UCLA, Co-Director ofthe SAMHSA-funded Pacific Southwest (HHS Region 9) Addictions Technology TransferCenter (PSATTC), and Co-PI of the Training and Dissemination contract with DHCS forthe Recovery Incentives Program: California’s Contingency Management Benefit andwith MT DPHHS for the HEART Demonstration: Montana’s Contingency ManagementProgram. Dr. Freese conducts evidence-based trainings on a wide variety of topicsincluding addressing the stimulant and opioid epidemics, the intersection of HIV,homelessness, and substance use, implementing integrated treatment, andimplementing evidence-based treatment practices. He has been a featured presenter atconferences and meetings across the US and internationally.
Beth A. Rutkowski, MPH, has been associated with UCLA Integrated Substance Useand Addiction Programs (ISAP) since December 2000, and currently serves as theDirector of Training, Co-Director of the SAMHSA-funded Pacific Southwest AddictionTechnology Transfer Center, and Co-Principal Investigator of Training andImplementation Support for both the Recovery Incentives Program: California’sContingency Management Benefit and the HEART Demonstration: Montana’sContingency Management Program. Ms. Rutkowski leads the development ofsynchronous and asynchronous training and intensive technical assistance activitiesand products and based on evidence-based substance use disorder treatmentinterventions and recovery approaches and organizes and conducts conferences andtrainings throughout the Pacific Southwest region (HHS Region 9, covering AZ, CA, HI,NV, and the six U.S. Affiliated Pacific Jurisdictions). She has co-authored and editeddozens of peer reviewed research articles, book chapters, special issues, and technicalreports on substance use disorder treatment.
Continuing Education Units:
3 CEUs
Certification Board Information
This training is approved for continuing education units by the boards listed here. Additional specifications can be found below.
NAADAC (The Association for Addiction Professionals)
Qualifies for NAADAC Credit: No
NBCC (National Board for Certified Counselors)
CASAT has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 6492. Programs that do not qualify for NBCC credit are clearly identified. CASAT is solely responsible for all aspects of the programs. (Continuing education hours and CEU's are synonymous for purposes of issuing CEU's from CASAT Learning)
Qualifies for NBCC Credit: Yes
NCB (Nevada Certification Board)
This course does not qualify.
Presentation materials are not for reproduction or distribution without specific written authorization. The opinions, findings, conclusions, and recommendations expressed in our courses are those of the author(s) and do not necessarily represent the official views of CASAT.
